Geovax Labs Stock Analysis
GOVX Stock | USD 2.70 0.31 10.30% |
GeoVax Labs is undervalued with Real Value of 3.47 and Target Price of 6.0. The main objective of GeoVax Labs stock analysis is to determine its intrinsic value, which is an estimate of what GeoVax Labs is worth, separate from its market price. There are two main types of GeoVax Labs' stock analysis: fundamental analysis and technical analysis.
The GeoVax Labs stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. GeoVax Labs is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. GeoVax Stock trading window is adjusted to America/New York timezone.
GeoVax |
GeoVax Stock Analysis Notes
The book value of the company was currently reported as 2.92. The company recorded a loss per share of 8.39. GeoVax Labs last dividend was issued on the 25th of September 2020. The entity had 1:15 split on the 31st of January 2024. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To learn more about GeoVax Labs call the company at 678 384 7220 or check out https://www.geovax.com.GeoVax Labs Investment Alerts
GeoVax Labs generated a negative expected return over the last 90 days | |
GeoVax Labs has high historical volatility and very poor performance | |
GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 81.53 K. | |
GeoVax Labs currently holds about 30.9 M in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
GeoVax Labs has a frail financial position based on the latest SEC disclosures | |
Latest headline from news.google.com: Alliance Global Partners Initiates Coverage of GeoVax Labs with Buy Recommendation - MSN |
GeoVax Labs Upcoming and Recent Events
Earnings reports are used by GeoVax Labs to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
28th of March 2024 Upcoming Quarterly Report | View | |
2nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
28th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
GeoVax Largest EPS Surprises
Earnings surprises can significantly impact GeoVax Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-05-04 | 2023-03-31 | -0.2 | -0.15 | 0.05 | 25 | ||
2022-11-09 | 2022-09-30 | -0.12 | -0.17 | -0.05 | 41 | ||
2023-08-09 | 2023-06-30 | -0.16 | -0.22 | -0.06 | 37 |
GeoVax Labs Environmental, Social, and Governance (ESG) Scores
GeoVax Labs' ESG score is a quantitative measure that evaluates GeoVax Labs' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of GeoVax Labs' operations that may have significant financial implications and affect GeoVax Labs' stock price as well as guide investors towards more socially responsible investments.
GeoVax Stock Institutional Investors
Shares | Alphamark Advisors, Llc | 2024-09-30 | 50.0 | Global Retirement Partners, Llc. | 2024-09-30 | 27.0 | Duncker Streett & Co Inc | 2024-09-30 | 24.0 | Royal Bank Of Canada | 2024-06-30 | 4.0 | Fmr Inc | 2024-09-30 | 1.0 | Jpmorgan Chase & Co | 2024-06-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 0.0 | Renaissance Technologies Corp | 2024-09-30 | 266 K | Geode Capital Management, Llc | 2024-09-30 | 56.7 K | Bank Of America Corp | 2024-06-30 | 44.8 K | Blackrock Inc | 2024-06-30 | 27.6 K |
GeoVax Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.4 M.GeoVax Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.80) | (2.94) | |
Return On Capital Employed | (4.64) | (4.41) | |
Return On Assets | (2.80) | (2.94) | |
Return On Equity | (4.51) | (4.28) |
Management Efficiency
GeoVax Labs has return on total asset (ROA) of (1.3435) % which means that it has lost $1.3435 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6239) %, meaning that it created substantial loss on money invested by shareholders. GeoVax Labs' management efficiency ratios could be used to measure how well GeoVax Labs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.94 in 2024. Return On Capital Employed is likely to rise to -4.41 in 2024. At this time, GeoVax Labs' Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.2 M in 2024, whereas Total Assets are likely to drop slightly above 4.9 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.27 | 2.38 | |
Tangible Book Value Per Share | 2.27 | 2.38 | |
Enterprise Value Over EBITDA | (0.27) | (0.29) | |
Price Book Value Ratio | 2.39 | 2.27 | |
Enterprise Value Multiple | (0.27) | (0.29) | |
Price Fair Value | 2.39 | 2.27 | |
Enterprise Value | 7.3 M | 6.9 M |
The leadership approach at GeoVax Labs' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Operating Margin (16.84) | Beta 3.109 | Return On Assets (1.34) | Return On Equity (3.62) |
Technical Drivers
As of the 27th of November, GeoVax Labs retains the Standard Deviation of 10.29, market risk adjusted performance of (0.31), and Risk Adjusted Performance of (0.04). GeoVax Labs technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.GeoVax Labs Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GeoVax Labs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GeoVax Labs. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GeoVax Labs Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GeoVax Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on GeoVax Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GeoVax Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Reynolds Mark over a month ago Acquisition by Reynolds Mark of 128000 shares of GeoVax Labs at 2.79 subject to Rule 16b-3 | ||
Spencer John N Jr over three months ago Acquisition by Spencer John N Jr of 8050 shares of GeoVax Labs at 2.17 subject to Rule 16b-3 | ||
David Dodd over three months ago Acquisition by David Dodd of 8000 shares of GeoVax Labs at 1.95 subject to Rule 16b-3 | ||
Chase Randal D over three months ago Acquisition by Chase Randal D of 9800 shares of GeoVax Labs at 0.19 subject to Rule 16b-3 | ||
John Sharkey over three months ago Acquisition by John Sharkey of 1000 shares of GeoVax Labs at 0.82 subject to Rule 16b-3 | ||
Mark Reynolds over six months ago Purchase by Mark Reynolds of 2000 shares of GeoVax Labs | ||
Mark Reynolds over a year ago Purchase by Mark Reynolds of 10000 shares of GeoVax Labs | ||
Mark Reynolds over a year ago Acquisition by Mark Reynolds of 100000 shares of GeoVax Labs subject to Rule 16b-3 | ||
Mark Reynolds over a year ago Purchase by Mark Reynolds of 8000 shares of GeoVax Labs |
GeoVax Labs Outstanding Bonds
GeoVax Labs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GeoVax Labs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GeoVax bonds can be classified according to their maturity, which is the date when GeoVax Labs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
GeoVax Labs Predictive Daily Indicators
GeoVax Labs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GeoVax Labs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 82731.77 | |||
Daily Balance Of Power | (0.94) | |||
Rate Of Daily Change | 0.9 | |||
Day Median Price | 2.85 | |||
Day Typical Price | 2.8 | |||
Price Action Indicator | (0.30) | |||
Period Momentum Indicator | (0.31) |
GeoVax Labs Corporate Filings
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 16th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
15th of October 2024 Other Reports | ViewVerify | |
8K | 1st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
25th of September 2024 Other Reports | ViewVerify |
GeoVax Labs Forecast Models
GeoVax Labs' time-series forecasting models are one of many GeoVax Labs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GeoVax Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About GeoVax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how GeoVax Labs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GeoVax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as GeoVax Labs. By using and applying GeoVax Stock analysis, traders can create a robust methodology for identifying GeoVax entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (155.80) | (148.01) | |
Operating Profit Margin | (199.18) | (189.22) | |
Net Loss | (198.97) | (189.02) | |
Gross Profit Margin | 0.35 | 0.37 |
Current GeoVax Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GeoVax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. GeoVax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
6.0 | Strong Buy | 5 | Odds |
Most GeoVax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand GeoVax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of GeoVax Labs, talking to its executives and customers, or listening to GeoVax conference calls.
GeoVax Stock Analysis Indicators
GeoVax Labs stock analysis indicators help investors evaluate how GeoVax Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading GeoVax Labs shares will generate the highest return on investment. By understating and applying GeoVax Labs stock analysis, traders can identify GeoVax Labs position entry and exit signals to maximize returns.
Begin Period Cash Flow | 27.6 M | |
Common Stock Shares Outstanding | 2.5 M | |
Total Stockholder Equity | 5.8 M | |
Property Plant And Equipment Net | 209.7 K | |
Cash And Short Term Investments | 6.5 M | |
Cash | 6.5 M | |
Accounts Payable | 2.8 M | |
Net Debt | -6.5 M | |
50 Day M A | 2.3334 | |
Total Current Liabilities | 3.5 M | |
Other Operating Expenses | 26.7 M | |
Non Current Assets Total | 1.4 M | |
Forward Price Earnings | 10.627 | |
Non Currrent Assets Other | 1.2 M | |
Stock Based Compensation | 1.1 M |
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.